OKYO compared with CRVO: revenue, margins and what each company keeps, and the suppliers and customers both name

OKYOOKYO Pharma Ltd

Mkt capRevenueRevenue

CRVOCervoMed Inc.

Mkt capRevenueRevenue

Compare

OKYOOKYO Pharma Ltd

CRVOCervoMed Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

OKYOOKYO Pharma Ltd

1.41▼−2.87%

Mkt cap$76.6MRevenue—Revenue—

CRVOCervoMed Inc.

1.51▼−2.51%

Regular sessionNov 4 '26

Mkt cap$23.4MRevenue$8,726Q4 FY25Revenue$4MFY25

Compare

Regular sessionNov 4 '26

OKYOOKYO Pharma Ltd

CRVOCervoMed Inc.

1.41▼−2.87%

Price

1.51▼−2.51%

$76.6M

Mkt cap

$23.4M

—

Revenue

$8,726Q4 FY25

—

Revenue

$4MFY25

OKYO1.41▼−2.87%vsCRVO1.51▼−2.51%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OKYO: latest quarter not drawable. CRVO: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OKYO 1

—On Target Therapeuticsunlistedsupplier

Shared 0

No shared counterparties.

Only CRVO 3

VRTXVertexsupplier

—NIA Grantunlistedsupplier

—NIAunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

OKYO, solidCRVO, dashed